Guo S, Zhang C, Mottamal M, Hossain A, et al. GLL398, an oral selective estrogen receptor degrader (SERD), blocks tumor growth in xenograft breast cancer models. Breast Cancer Res Treat 2020 Feb 6. pii: 10.1007/s10549-020-05558.
PMID: 32030569